The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode

被引:53
作者
Arolas, JL
Popowicz, GM
Lorenzo, J
Sornmerhoff, CP
Huber, R
Aviles, FX [1 ]
Holak, TA
机构
[1] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Spain
[2] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra 08193, Spain
[3] Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany
[4] Univ Munich, Klinikumsstandort Innenstadt, Klin Chem & Klin Biochem Abt, D-80336 Munich, Germany
关键词
metallo-carboxypeptidase; carboxypeptidase inhibitor; inhibitor-enzyme complex; crystal structure; pro-fibrinolytic drug;
D O I
10.1016/j.jmb.2005.05.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tick carboxypeptidase inhibitor (TCI) is a proteinaceous inhibitor of metallo-carboxypeptidases present in the blood-sucking tick Rhipicephalus bursa. The three-dimensional crystal structures of recombinant TO bound to bovine carboxypeptidase A and to human carboxypeptidase B have been determined and refined at 1.7 angstrom and at 2.0 angstrom resolution, respectively. TCI consists of two domains that are structurally similar despite the low degree of sequence homology. The domains, each consisting of a short alpha-helix followed by a small twisted antiparallel beta-sheet, show a high level of structural homology to proteins of the beta-defensin-fold family. TCI anchors to the surface of mammalian carboxypeptidases in a double-headed manner not previously seen for carboxypeptidase inhibitors: the last three carboxy-terminal amino acid residues interact with the active site of the enzyme in a way that mimics substrate binding, and the N-terminal domain binds to an exosite distinct from the active-site groove. The structures of these complexes should prove valuable in the applications of TCI as a thrombolytic drug and as a basis for the design of novel bivalent carboxypeptidase inhibitors. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:489 / 498
页数:10
相关论文
共 47 条
  • [1] Comparative analysis of the sequences and three-dimensional models of human procarboxypeptidases A1, A2 and B
    Aloy, P
    Catasús, L
    Villegas, V
    Reverter, D
    Vendrell, J
    Avilés, FX
    [J]. BIOLOGICAL CHEMISTRY, 1998, 379 (02) : 149 - 155
  • [2] A carboxypeptidase inhibitor from the tick Rhipicephalus bursa
    Arolas, JL
    Lorenzo, J
    Rovira, A
    Castellà, J
    Aviles, FX
    Sommerhoff, CP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (05) : 3441 - 3448
  • [3] ADVANCES IN METALLO-PROCARBOXYPEPTIDASES - EMERGING DETAILS ON THE INHIBITION-MECHANISM AND ON THE ACTIVATION PROCESS
    AVILES, FX
    VENDRELL, J
    GUASCH, A
    COLL, M
    HUBER, R
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 211 (03): : 381 - 389
  • [4] Thrombin activatable fibrinolysis inhibitor: Not just an inhibitor of fibrinolysis
    Bajzar, L
    Jain, N
    Wang, P
    Walker, JB
    [J]. CRITICAL CARE MEDICINE, 2004, 32 (05) : S320 - S324
  • [5] Structural basis of the endoproteinase-protein inhibitor interaction
    Bode, W
    Huber, R
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2): : 241 - 252
  • [6] NATURAL PROTEIN PROTEINASE-INHIBITORS AND THEIR INTERACTION WITH PROTEINASES
    BODE, W
    HUBER, R
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 204 (02): : 433 - 451
  • [7] BOURNA BN, 2003, J THROMB HAEMOST, V1, P1566
  • [8] 3-DIMENSIONAL STRUCTURE OF POTATO CARBOXYPEPTIDASE INHIBITOR IN SOLUTION - A STUDY USING NUCLEAR-MAGNETIC-RESONANCE, DISTANCE GEOMETRY, AND RESTRAINED MOLECULAR-DYNAMICS
    CLORE, GM
    GRONENBORN, AM
    NILGES, M
    RYAN, CA
    [J]. BIOCHEMISTRY, 1987, 26 (24) : 8012 - 8023
  • [9] Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism
    Eichinger, S
    Schönauer, V
    Weltermann, A
    Minar, E
    Bialonczyk, C
    Hirschl, M
    Schneider, B
    Quehenberger, P
    Kyrle, PA
    [J]. BLOOD, 2004, 103 (10) : 3773 - 3776
  • [10] Tethering: Fragment-based drug discovery
    Erlanson, DA
    Wells, JA
    Braisted, AC
    [J]. ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2004, 33 : 199 - 223